From: Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms
Variable
Patient group (n = 27)
Control group (n = 27)
p
Male/female (n/n)
6/21
–
Age (years)
56 (52, 63)
52 (50, 57)
0.191